OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
The speaker will highlight the urgent and growing global threat posed by antimicrobial resistance (AMR) in tuberculosis (TB) and other non-tuberculous mycobacterial (NTM) infections. This talk will address the major challenges in developing new therapeutic strategies to target the varied physiological states of these resilient pathogens and their exceptional ability to evade host defence mechanisms across human, animal, and environmental settings, within biofilm-forming microbiomes. Drawing on recent research findings, the seminar will discuss the validation of novel therapeutic targets that could accelerate drug design and discovery efforts. In particular, it will highlight promising work on the repurposing of carprofen, a non-steroidal anti-inflammatory drug, to help reverse drug resistance in TB and NTM diseases.
This interdisciplinary seminar is designed to engage a broad audience, including researchers in basic science, public health professionals, clinicians, and industry experts, all united by a shared interest in tackling one of the most pressing health threats of our time.
